Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ok. Know the date of record? Thanks. :)
The NOUV dividend should happen any day, according to the 11/15/18 PR:
Puration, Inc. (USOTC: PURA) ("PURA") today announced that Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) ("NOUV") has formally declared a 1:5 stock dividend whereby NOUV common stock will be issued to the shareholders of PURA at a ratio of one NOUV common share for every five shares of PURA held on the yet to be determined date of record. The NOUV board of directors as resolved to restructure NOUV and issue the stock dividend to PURA shareholders in conjunction with PURA's spinoff of its cannabis cultivation business to NOUV announced October 4, 2018. Subject to necessary regulatory and administrative authority approvals, NOUV plans to set a date of record for the dividend for approximately 30 days from now, and a pay date just after the first of next year.
What is the Date of Record for the NOUV dividend? I bought and sold PURA throughout November and December, but want to know the DoR so that I can determine what to expect from NOUV. Also, when is this dividend supposed to happen? Here is the PR from November 15th... https://www.prnewswire.com/news-releases/puration-inc-announces-1-5-nouveau-stock-dividend-declaration-892393373.html
"Puration, Inc. (USOTC: PURA) ("PURA") today announced that Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) ("NOUV") has formally declared a 1:5 stock dividend whereby NOUV common stock will be issued to the shareholders of PURA at a ratio of one NOUV common share for every five shares of PURA held on the yet to be determined date of record. The NOUV board of directors as resolved to restructure NOUV and issue the stock dividend to PURA shareholders in conjunction with PURA's spinoff of its cannabis cultivation business to NOUV announced October 4, 2018. Subject to necessary regulatory and administrative authority approvals, NOUV plans to set a date of record for the dividend for approximately 30 days from now, and a pay date just after the first of next year."
We should see this move up over .17, maybe .18. I'm not sure how much more it can go without news, but we all know it's coming. =)
With an expected move up plus the NOUV dividend incoming, we should challenge the .10 mark. Long term, it's a great buy and/or hold.
Agreed, the run will come very soon. Maybe this week. Thanks for your info.
This is about to run back up to maybe .0015+, maybe this week.
The ask is weak up to .0020
Folks, this will be trading in the Dollars within two years. Buy and hold. Stop playing the day-trading game.
"We are currently looking for joint ventures..." --Dr. Eyal Ballan, Co-Founder and CTO
Awesome news! Another patent application!
Thank you. It would be nice to know the details, but we'll know soon enough. Regardless, PURA is poised to shoot up shortly... I suspect we'll see .12+ by the second week of January.
Does anyone know what the effective dividend date was to show you had shares of PURA in order to get NOUV shares? Sorry, if I'm not saying it right.
Great buy in opportunity here. Once .0842 breaks, it'll run way up over .09 to .10+
AmericanBulls: PURA BUY Recommendation .25 https://ih.advfn.com/stock-market/USOTC/puration-inc-pc-PURA/stock-news/78941184/pura-buy-recommendation-following-farm-act-0-25
PURA BUY RECOMMENDATION FOLLOWING FARM ACT - $0.25 PPS REBOUND ON HORIZON
New York, NY -- December 21, 2018 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) has a BUY recommendation from AmericanBulls.com following President Trump signing the Farm Bill into law and legalizing hemp farming. The company also announced yesterday exceeding its $1 million sales goal for 2018 and setting a $5 million sales goal for 2019. The company is thriving and growing and showing now reason not to be trading at the $0.25 PPS high reached a few weeks ago and supported by a sustained Goldman Small Cap Research PPS Target Recommendation. Bulls make money on increasing share prices and bears make money selling short and buying shares to fill short sales executed at a higher price. REGSHO data (see below) shows that PURA has been consistently sold short for weeks now. Yesterday and this morning the PURA PPS rallied only to have cold water poured on the rally by Citadel Securities (CDEL) boxing the bid and offer and scuttling the rally. CDEL has dominated the box for weeks while the PPS has gone sideways with likely short sellers picking up the shares of legitimate and frustrated shareholders. Farm Act news and positive sales results from PURA sparked the rally that threatened short position holders. The rally and subsequent effort to scuttle the rally also exposed the short position. The short position can’t likely hold on much longer. PURA looks to have even more good news coming to include a pending dividend. The rally showed the shorts control is weakening. A $0.25 PPS rebound looks to be on the horizon.
AmericanBulls Buy Recommendation:
“Our system’s recommendation today is to BUY. The BULLISH HARAMI pattern finally received a confirmation because the prices crossed above the confirmation level which was at 0.0872, and our valid average buying price stands now at 0.0880.
Let’s jump on our white horses and go for a bullish ride. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. Most probably, it is the right time to participate in bullish fervor. The market is telling you about a new profit. Do not miss this bullish opportunity”
The chart shows likely resistance at .0059. If it breaks that, the next resistance is at .001 and .002.
New here: Is it software or a Hemp company?
The chart shows UBQU runs way up each Dec-Jan. It's happening again... could run to .0059, or higher if it breaks through resistance.
Any moment, any day, PURA will run to .12+, as it should.
Folks, get in now and hold. This is BIG.
First Shipment Of Hemp-Derived CBD Infused Private Label Water For Pharmaceutical Client
https://globenewswire.com/news-release/2018/12/13/1666916/0/en/Kali-Extracts-and-Puration-Announce-First-Shipment-Of-Hemp-Derived-CBD-Infused-Private-Label-Water-For-Pharmaceutical-Client.html
This Farm Bill news is monumental. We should hit .10 by this afternoon. Perhaps .11-.12+ by the end of the week, if not even more. Some don't recognize what the FARM BILL is going to mean to PURA. It's going to bring the value notably higher. All time high (.25) by early January.
This 8k is a relief. Good job management. Some will sell in the morning, but the smart folks are gearing up for the bigger news due anytime in December. This isn't pumping, just realistic. 3%'ish due over a six month period is a drop in the bucket. The naysayers will try to spin it, but this is a win for shareholders.
We have 148.49 million shares outstanding. If, over the next 6 months, we pay out $750,000 to Ziv, that'll cost us about 4.3 million shares at .175 per. Folks, that's only a 2.9% difference. Today closed at .1484. A 2.9% difference would mean .1440. It's less than half a penny. Am I missing something?
The three expected good news events due by year's end will still shoot this way up. Don't get suckered into selling your shares.
Nice! Should push up tomorrow (Wednesday) to .50+
When the MAXM ASK breaks, this will rise up.
Finally! CNBX Prepares ISO Application for Its Diagnostics Platform Towards Commercialization https://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-prepares-iso-application-for-its-diagnostics-platform-towards-commercialization-300763536.html
I'm guessing we'll see this rise up to .50+
TEL AVIV, Israel and BETHESDA, Maryland, Dec. 11, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a world leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has started the accreditation process in accordance with ISO 15189:2012 for its drug screening and diagnostics laboratory, which it expects to receive by the end of next year. ISO is the accepted "International Organization for Standardization", and ISO 15189:2012 is the international standard for quality management and competence for Medical Laboratories by regulators and accrediting bodies. This accreditation demonstrates to the marketplace and to regulators that the medical laboratory has met the highest scientific standards for accreditation and compliance.
Through its 100% owned subsidiary, G.R.I.N ULTRA, Israel, Cannabics Pharmaceuticals will leverage its state-of-the-art high throughput screening platform utilizing cannabis extracts on human cancer cells and recommend the optimal cannabinoid treatment for each patient based on their own biopsies and personalized clinical data.
Eyal Ballan, Co-founder and chief Scientist of Cannabics said, "Cannabics is committed to developing novel cannabinoid-based drugs and providing the highest quality diagnostic services for cancer patients. We are focused on whole plant extraction, distinguishing between variations in cannabinoid profiles, supporting decision making in cancer treatment which can provide physicians, caregivers and patients a whole new layer of data that was unavailable to them previously, as well as help provide valuable insight which will reflect on their medical cannabis treatment regime."
The accreditation will allow Cannabics to commercialize its diagnostics and allow the analysis of patients' biopsies in our new laboratory, in which drug sensitivity tests will deliver a personalized data report which may be used for more specified treatment decisions.
Solid day and more good news. Love it.
Just signed #FarmBill18 Conference Committee Report. Consensus reached! Next stops: Full House➡️ Senate➡️ President pic.twitter.com/KxNuy1jUTi
— James Comer (@JamesComer) December 10, 2018
We should see .12-.13+ within the next few weeks.
NEWS: For PURA, Kali Announces $300,000 Contract to Produce Hemp-Derived CBD Extract https://www.prnewswire.com/news-releases/kali-extracts-inc-announces-300-000-contract-to-produce-hemp-derived-cbd-extract-for-puration-inc--836538544.html
DALLAS , December 10, 2018 /PRNewswire/ --
Kali-Extracts, Inc. (Kali, Inc.(KALY) dba/Kali-Extracts, Inc.) (USOTC: KALY) today announced a $300,000 contract with Puration, Inc.(PURA) ("PURA") to produce custom hemp-derived CBD extracts. Kali-Extracts recently acquired a patented cannabis extraction process, that comes with a substantial volume of associated clinical research, in a reverse merger transaction with NCM Biotech. Kali-Extracts is accordingly in the process of rapidly updating the company's public filings with OTCMarkets to both post the legacy operations past-due filings and to reflect the current cannabis extraction business. Kali-Extracts has a new website (http://www.kali-extracts.com) that includes a presentation of the company's new cannabis extraction business plan. Now, less than one month after the reverse merger transaction, where Kali-Extracts acquired the patented cannabis extraction process, the company has signed its first revenue producing contract.
"With the legalization of hemp farming on the near horizon as drafted into the pending 2018 Farm Act, the flood gates are about to open for Kali-Extracts," said Frederick Ferri, the founder of NCM Biotech, and the incoming CEO of Kali-Extracts. "I am already receiving daily inquiries to formulate custom hemp-derived CBD extractions. The pending legalization of hemp farming, combined with the recent DEA removal of CBD from schedule 1, is igniting the commercialization of hemp-derived CBD concentrates for a multitude of applications from pharmaceutical to sports nutrition to over the counter pain management to general health and wellness."
Kali-Extracts Partnership with Puration, Inc.(PURA)
Kali-Extracts and Puraiton, Inc. have a long-term partnership that predates the reverse merger of NCM Biotech into Kali-Extracts. Puration has the sole license of the Kali-Extracts patented cannabis extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT." In conjunction with Puration's(PURA) industry specific license, Puration(PURA) currently produces EVERx CBD Sports Water, the leading CBD infused water in the sports nutrition market. Puration(PURA) has trailing twelve-month revenues of approximately $1 million. More recently, Kali-Extracts and Puration(PURA), with two other partners, have together formed a joint venture company (JV) titled US Cannabis Health. The purpose of the JV is to pursue partnerships with pharmaceutical companies to produce cannabis extract pharmaceutical applications. The JV has recently signed its first agreement, and in conjunction with that agreement, Puration(PURA) will produce private labeled hemp-derived CBD infused water under the client pharmaceutical company's name. Puration has engaged Kali-Extracts to make a custom hemp-derived CBD extract specific to the requirements for the private labeled hemp-derived CBD water Puration(PURA) will produce for the pharmaceutical company.
The chart shows me we're headed to .12+ by January. There are too many good things happening and after the recent acquisitions in this sector, PURA is very well-positioned to shoot well north of where they are now.
When PURA gets bought out for $1 or more, my life will change for the better. That's how much I've invested and how much believe in this company. Could a stake or buyout come in less than $1, sure. But many feel it'll be far more. Hard to know. I also feel strongly that this company's current PPS is very, very low. We'll see .12+ by year's end.
This could hit.09+ this morning. Whether it holds or not is to be determined. Hell, one of these days soon it'll run much further up and challenge the .13-.15 area.
The ASK is weak up to .10. I'd love to see us push back there.
Wow... The Illegal Burger chain is impressive! "Illegal Burger was recently recognized for its same store year over year growth outpacing all its competition as announced in National Restaurant News. Now Illegal Burger and El Senor Sol will lead the way by introducing CBD infused beverages to the menu."
GREAT NEWS! Two new chains selling our water! https://www.prnewswire.com/news-releases/wcvc-announces-illegal-burger-and-el-senor-sol-to-carry-everx-cbd-sports-water-from-puration-300761340.html
Update: Puration Anticipates Substantial Sales Acceleration From Projected Hemp-Derived CBD Market Expansion From $591 Million to $22 Billion by 2022 https://www.prnewswire.com/news-releases/puration-anticipates-substantial-sales-acceleration-from-projected-hemp-derived-cbd-market-expansion-from-591-million-to-22-billion-by-2022-813469669.html
DALLAS, December 4, 2018 /PRNewswire/ --
Puration, Inc. (USOTC: PURA) today released an update on its end of year sales drive to reach or exceed $1 million in sales for 2018 and to add insight into the 2019 anticipated sales growth.
The company recently reported its revenue for the nine months ending September 30, 2018 at $868,300 representing an increase of over 400% since the company reported $168,000 for the same period last year. The company also realized a 50% profit margin reporting a $448,800 bottom line for the nine months ending September 30, 2018. Management believes the $1 million in annual sales benchmark is within reach for 2018 and continues pushing to insure success. The company today announced signing a new distributor, Savannah Distributing Company , opening up sales of Puration's EVERx CBD Sports Water for the first time within the Southeast United States. Management anticipates additional geographic distribution expansion announcements before the end of the year.
Recent analyst coverage of Puration included a $3 million estimated 2019 revenue projection. Following the analyst coverage, Puration announced a $1 million agreement to produce a new private labeled CBD infused bottled water for a health care industry firm. With what appears to be the imminent legalization of hemp and hemp-derived CBD in the United States under the 2018 Farm Act, demand for CBD infused beverages could expand rapidly.
The Motley Fool:
"If the bill makes it through Congress and is signed by President Trump, as widely expected, industrial hemp should be legal on Jan. 1, 2019. If this occurs, the U.S. market for hemp -- and its derivatives -- is expected to soar. The hemp-derived CBD market is projected to rocket from about $591 million this year to $22 billion by 2022, according to the Brightfield Group. That's a whopping 37-fold increase in just four years!"
Agree. While $50 per share in five years is likely excessive, $5+ is more realistic.
Expansion into the Southeast=VERY good for business. =)
New Distributor signed. 1st order received! Expanding into Southeast... Savannah Distributing Company! =) https://ih.advfn.com/p.php?pid=nmona&article=78816281